Home LiteratureArticle Details
PMID: 2072377 Published · ppublish English Journal Article

Susceptibility to desferrioxamine: a new test for the identification of Staphylococcus epidermidis.

Journal of medical microbiology ·Vol. 35 ·No. 1 ·1991-07-00 ·Pages 45-8

Lindsay JA, Riley TV

Abstract

The ability to identify Staphylococcus epidermidis quickly and accurately has become increasingly important in clinical microbiology. Susceptibility to desferrioxamine, an iron-chelating agent, was investigated as a new test for the identification of S. epidermidis. All strains of S. epidermidis and S. hominis tested were susceptible to a 1000-micrograms disk of desferrioxamine when grown on brain heart infusion agar. All other strains of coagulase-negative staphylococci, S. aureus and micrococci were resistant. As a single test, susceptibility to desferrioxamine was 96.4% efficient in identifying S. epidermidis; when combined with additional tests such as alkaline phosphatase production and fermentation of trehalose, the efficiency improved to 100%. Desferrioxamine disks were easy to prepare, stable and inexpensive. The test was simple to perform and interpret and should readily find application in clinical microbiology laboratories.

MeSH Terms
Culture Media Deferoxamine/pharmacology Humans Microbial Sensitivity Tests Staphylococcus epidermidis/drug effects,growth & development
Chemicals
Culture Media Deferoxamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lindsay J A
Department of Microbiology, University of Western Australia, Nedlands.
Riley T V
Article Info
Journal
Journal of medical microbiology
Abbr.
J Med Microbiol
ISSN
0022-2615
Published
1991-07-00
Pages
45-8
Language
English
Region
England
NLM ID
0224131
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com